FDA Inspection 1195318 — Piramal Pharma Solutions Inc.

Piramal Pharma Solutions Inc. — FEI 3006419237

The FDA completed an inspection of Piramal Pharma Solutions Inc. on January 10, 2023 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 10, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, KY (United States)